Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.76 is 29% below its 3-year average of -1.36, near the low end of its 3-year range (-1.76–-1.13).
35.91% below its 12-month average of -1.29.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.51.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.76
EARNINGS PER SHARE (EPS) AVG TTM
-1.29
EARNINGS PER SHARE (EPS) AVG 3Y
-1.36
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.91%
CURRENT VS 3Y AVG
-29.41%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CeriBell, Inc.
Market Cap
$931.87M
Earnings Per Share (EPS)
-1.76
TTM Avg
-1.29
3Y Avg
-1.36
5Y Avg
N/A
Market Cap
$928.59M
Earnings Per Share (EPS)
-3.37
TTM Avg
-2.60
3Y Avg
-2.33
5Y Avg
-2.16
Market Cap
$925.27M
Earnings Per Share (EPS)
-3.85
TTM Avg
-2.71
3Y Avg
-1.96
5Y Avg
-1.55
Market Cap
$916.77M
Earnings Per Share (EPS)
0.72
TTM Avg
0.64
3Y Avg
0.54
5Y Avg
0.47
Market Cap
$890.55M
Earnings Per Share (EPS)
0.77
TTM Avg
-0.09
3Y Avg
-1.31
5Y Avg
-0.73
Market Cap
$885.96M
Earnings Per Share (EPS)
0.78
TTM Avg
-0.28
3Y Avg
-0.36
5Y Avg
-0.51
Market Cap
$975.87M
Earnings Per Share (EPS)
-2.97
TTM Avg
-9.41
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$982.12M
Earnings Per Share (EPS)
0.71
TTM Avg
-1.77
3Y Avg
-1.98
5Y Avg
-1.86
Market Cap
$987.45M
Earnings Per Share (EPS)
-1.05
TTM Avg
-1.23
3Y Avg
-0.94
5Y Avg
-0.94
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CeriBell, Inc. (CBLL) | $931.87M | -1.76 | -1.29 | -1.36 | N/A |
| Kura Oncology, Inc. (KURA)vs › | $928.59M | -3.37 | -2.60 | -2.33 | -2.16 |
| MoonLake Immunotherapeutics (MLTX)vs › | $925.27M | -3.85 | -2.71 | -1.96 | -1.55 |
| HealthStream, Inc. (HSTM)vs › | $916.77M | 0.72 | 0.64 | 0.54 | 0.47 |
| Bioventus Inc. (BVS)vs › | $890.55M | 0.77 | -0.09 | -1.31 | -0.73 |
| Arbutus Biopharma Corp (ABUS)vs › | $885.96M | 0.78 | -0.28 | -0.36 | -0.51 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $975.87M | -2.97 | -9.41 | -6.16 | -6.16 |
| MeiraGTx Holdings plc (MGTX)vs › | $982.12M | 0.71 | -1.77 | -1.98 | -1.86 |
| Aktis Oncology, Inc. (AKTS)vs › | $987.45M | -1.05 | -1.23 | -0.94 | -0.94 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $987.11M | N/A | N/A | N/A | N/A |
Trailing EPS (TTM)
$-1.76
Forward EPS (Est.)
$-1.97
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.46 |
| 2024-12-31 | -1.13 |
| 2023-12-31 | -1.26 |
| 2022-12-31 | -1.59 |
